Penbraya Side Effects
Generic name: meningococcal group acwy conjugate-group b vaccine (cvx 316)
Note: This document contains side effect information about meningococcal group acwy conjugate-group b vaccine (cvx 316). Some dosage forms listed on this page may not apply to the brand name Penbraya.
Applies to meningococcal group acwy conjugate-group b vaccine (cvx 316): intramuscular suspension.
Warning
You should not receive the vaccine a second time if you had a life threatening allergic reaction after the first shot.
Get emergency medical help if you have signs of an allergic reaction: hives, difficult breathing, swelling of your face, lips, tongue, or throat.
Keep track of all side effects you have, be sure to tell the vaccination provider if the previous shot caused any side effects.
You should not receive a second shot if you had a life-threatening allergic reaction after the first shot.
Becoming infected with meningococcal disease and developing meningitis is much more dangerous to your health than receiving this vaccine. Any vaccine may cause side effects but the risk of serious side effects is low.
You may feel faint after receiving this vaccine. Your doctor may want you to remain under observation during the first 15 minutes after the injection.
Common side effects may include:
-
feeling tired;
-
muscle or joint pain;
-
chills; or
-
pain, redness, swelling, or irritation where the medicine was injected.
This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects.
For Healthcare Professionals
Applies to meningococcal group acwy conjugate-group b vaccine (cvx 316): intramuscular suspension.
General
The most common adverse reactions reported after receiving both doses of this vaccine were pain at the injection site, muscle pain, fatigue, headache, injection site swelling and redness, joint pain, and chills.[Ref]
Gastrointestinal
Very common (10% or more): Diarrhea (up to 11%)
Common (1% to 10%): Vomiting
Hypersensitivity
Postmarketing reports: Allergic reaction (including anaphylaxis)[Ref]
Local
Very common (10% or more): Injection site pain (up to 89.3%), injection site redness (up to 25.9%), injection site swelling (up to 25%)
Musculoskeletal
Very common (10% or more): Joint pain (up to 20.2%), muscle pain (up to 25.7%)[Ref]
Other
Common (1% to 10%): Fever
Nervous system
Very common (10% or more): Chills (up to 20.1%), fatigue (up to 52.1%), headache (up to 46.8%)
Postmarketing reports: Syncope (fainting)[Ref]
More about Penbraya (meningococcal group acwy conjugate-group b vaccine (cvx 316))
- Check interactions
- Compare alternatives
- Drug images
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: bacterial vaccines
- En español
Patient resources
Professional resources
Related treatment guides
References
1. Product Information. Penbraya (cvx 316) (meningococcal group ACWY conjugate-group B vaccine (cvx 316)). Pfizer U.S. Pharmaceuticals Group. 2024.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Some side effects may not be reported. You may report them to the FDA.